Search for Clinical Trial Results

Inflammatory Breast Neoplasms - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Case-Control Study of Inflammatory Breast Cancer in North Africa Condition: Inflammatory Breast Cancer Date: 2008-11-18 |
Recruiting |
Study Name: Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer Condition: Inflammatory Breast Cancer Date: 2011-05-25 Interventions:
|
Recruiting |
Study Name: Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer Condition: Inflammatory Breast Cancer (IBC) Date: 2016-08-09 Interventions:
|
Completed |
Study Name: Establishing an Inflammatory Breast Cancer Registry Condition: Inflammatory Breast Cancer Date: 2006-06-19 |
Recruiting |
Study Name: Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy Condition: Inflammatory Breast Carcinoma Date: 2013-06-25 Interventions:
|
Completed |
Study Name: Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia Condition: Inflammatory Breast Cancer Date: 2006-06-23 |
Completed |
Study Name: Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer Condition: Inflammatory Breast Cancer Date: 2014-12-14 Interventions:
|
Recruiting |
Study Name: A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer Condition:
|
Not yet recruiting |
Study Name: Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer Condition:
Date: 2016-09-02 Interventions: |
Recruiting |
Study Name: A Study of Anti-PD-1 (Pembrolizumab) + Hormonal Therapy in HR-positive Localized IBC Patients With Non-pCR to Neoadjuvant Chemotherapy Condition:
Date: 2016-11-21 Interventions: Drug: Pembrolizumab Pembrolizumab 200 mg administered on day 1 of each 3-week cycle as approximately 30 |